Search by Title Article Topic - Any -AdvocacyCertificationClinical TrialsCoronavirusEarly CareerFellowshipFuture LeadersHeart Failure AwarenessHeart Failure GuidelinesHFSA Annual Scientific MeetingHFSA AwardsHFSA Board Certification ReviewHFSA CommitteesHFSA Comprehensive Heart Failure ReviewHFSA Learning CenterHFSA MembershipIn The NewsIndustryJournal of Cardiac FailureMentorshipNursingPartnersPatient ResourcePodcastsPresident's UpdatesPress ReleaseProfessional DevelopmentProvider EducationResearchSocial MediaSubmissionsWomen in Heart Failure Article Type - Any -HFSA NewsIndustry NewsPatient NewsPractice News Mar 24 2021 | U.S. Food and Drug Administration (FDA) Accepts Bristol Myers Squibb’s Application for Mavacamten in Symptomatic Obstructive Hypertrophic Cardiomyopathy (oHCM) Industry News In The News Industry Read More Mar 18 2021 | ABIM Extends MOC Requirement Deadlines Through 2022 Practice News In The News Professional Development Read More Mar 1 2021 | Heart Failure Society of America, Heart Failure Association of European Society of Cardiology, and Japanese Heart Failure Society Release Universal Definition and Classification of Heart Failure HFSA News Heart Failure Guidelines In The News Journal of Cardiac Failure Research Read More Jan 21 2021 | Dr. Barry Massie, Past President of the Heart Failure Society of America, Passes HFSA News In The News Read More Jan 13 2021 | US FDA accepts supplemental New Drug Application for Jardiance® (empagliflozin) for adults with heart failure with reduced ejection fraction Industry News In The News Industry Read More Pagination Current page 1 Page 2 Page 3 Page 4 Next page Next › Last page Last »
Mar 24 2021 | U.S. Food and Drug Administration (FDA) Accepts Bristol Myers Squibb’s Application for Mavacamten in Symptomatic Obstructive Hypertrophic Cardiomyopathy (oHCM) Industry News In The News Industry Read More
Mar 18 2021 | ABIM Extends MOC Requirement Deadlines Through 2022 Practice News In The News Professional Development Read More
Mar 1 2021 | Heart Failure Society of America, Heart Failure Association of European Society of Cardiology, and Japanese Heart Failure Society Release Universal Definition and Classification of Heart Failure HFSA News Heart Failure Guidelines In The News Journal of Cardiac Failure Research Read More
Jan 21 2021 | Dr. Barry Massie, Past President of the Heart Failure Society of America, Passes HFSA News In The News Read More
Jan 13 2021 | US FDA accepts supplemental New Drug Application for Jardiance® (empagliflozin) for adults with heart failure with reduced ejection fraction Industry News In The News Industry Read More
